July 2026
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the impact of a mobile message-based intervention on cardiovascular risk factors in patients with uncontrolled type 2 diabetes, finding significant reductions in hemoglobin A1C levels.
Interventions
SMS text messaging behavioral intervention for health promotion
Outcomes
BMIDiastolic blood pressureFasting Plasma Glucose (FPG)+7 more
Added to Dediabetes Jul 18, 2026RCTs
This study examined the effects of Naltrexone/Bupropion on hepatic health in patients with Type 2 diabetes and obesity, finding significant improvements in hepatic steatosis and fibrosis markers.
Interventions
Naltrexone/Bupropion (NB)
Outcomes
Change in Hepatic Steatosis Index (HSI)Change in Metabolic Dysfunction-Associated Fibrosis-5 (MAF-5)FIB-4 index
Added to Dediabetes Jul 18, 2026RCTs
This study investigated the impact of non-surgical periodontal therapy on renal function and glycaemic control in chronic kidney disease patients, finding significant improvements in eGFR and HbA1c levels.
Interventions
Non-surgical periodontal treatment
Outcomes
C-reactive proteinEstimated glomerular filtration rateHbA1c+1 more
Added to Dediabetes Jul 18, 2026RCTs
A community-based nutrition education program improved metabolic and behavioral outcomes in adults with type 2 diabetes (T2D) in a low-resource setting.
Interventions
Remote nutrition education on low-carbohydrate diet
Outcomes
Diastolic blood pressureHbA1cLipid parameters+4 more
Added to Dediabetes Jul 18, 2026RCTs
The study evaluated the effectiveness of low-frequency self-monitoring of blood glucose in non-insulin treated type 2 diabetes patients, finding it to be sufficient and safe.
Interventions
Self-monitoring of blood glucose
Outcomes
HbA1cTreatment adherence
Added to Dediabetes Jul 18, 2026RCTs
Polyethylene glycol loxenatide (PEG-Loxe) for weight reduction and metabolic improvement in super-obese patients with type 2 diabetes.
Interventions
PEG-Loxe 300 µg/weekPEG-Loxe 400 µg/week
Outcomes
Body weightHDL cholesterolHbA1c+1 more
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the impact of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes, finding significant improvements in periodontal health but no significant change in HbA1c levels.
Interventions
Non-surgical periodontal treatment
Outcomes
Clinical attachment levelGingival Index (GI)HbA1c+3 more
Added to Dediabetes Jul 18, 2026RCTs
This pilot randomized controlled trial evaluated a 12-week device-measured physical activity intervention on glycaemic control and visual functioning in individuals newly diagnosed with AGT in Ghana, finding a significant reduction in HbA1c levels.
Interventions
Exercise therapySynchronous online type 1 diabetes psychoeducational program for school staff
Outcomes
HbA1cImprovement in contrast sensitivity in the left eyeImprovement in contrast sensitivity in the right eye
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the efficacy of pregabalin in treating painful diabetic peripheral neuropathy. Higher doses of pregabalin (300 mg and 600 mg) significantly reduced pain scores compared to placebo.
Interventions
Pregabalin 150 mg/dayPregabalin 300 mg/dayPregabalin 75 mg/day+1 more
Outcomes
Mean pain score reduction compared to placebo (Pregabalin 150 mg/day)Mean pain score reduction compared to placebo (Pregabalin 75 mg/day)Mean pain score reduction with Pregabalin 300 mg/day+3 more
Added to Dediabetes Jul 18, 2026RCTs
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
Interventions
Insulin therapyUsual care
Outcomes
C-peptideFasting Plasma Glucose (FPG)Fasting insulin levels+3 more